NXGENPORT

NXgenPort Inc is addressing an unmet need in cancer care by remotely monitoring patients between chemotherapy visits with an implanted Smart Port. By measuring cell counts and heart function in vivo, NGP will alert physicians to signs of infection, reduce hospitalizations, and gather important physiological data to improve patient outcomes. There is additional value for cancer researchers and drug delivery stakeholders to remotely monitor a participant's biological response to interventions.